Skip to content

Author

M. Schlaak

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Cancer survivorship in malignant melanoma

Robust long‐term survival data have transformed the prognosis of metastatic melanoma. For combination therapy with immune checkpoint inhibitors (ICIs), 10‐year melanoma‐specific survival rates now exceed 50 %, and durable disease control is achievable in a substantial proportion of patients, including those with brain...

Markus Reitmajer, S. Dugas-Breit, C. Blomen et al. · 0 citations
Preprint Aug 2026

DNA Methylation Profiling in Melanoma: From Lesion Classification to Therapeutic Stratification

It is demonstrated that methylation-based models can capture both diagnostic identity and clinically relevant disease stratification, supporting DNA methylation as a promising biomarker for further validation and potential clinical translation.

J. Winterstein, L. Heinlein, G. Raddatz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.